Open help menu
On-Demand

Approaches to Opioid Use Disorder

Angelo Asheh, DO, MPH
|

Information

Calling all Physicians & Nurses

This workshop offers CMEs & CNEs!

Learning Objectives

Participants will be able to:

  • Describe the epidemiology and impact of opioid use disorder.

  • Identify diagnostic criteria for OUD based on DSM-5.

  • Discuss pharmacological and non-pharmacological treatment options.

  • Distinguish strategies to address stigma and promote patient-centered care.

Educational Goal

To increase knowledge of the epidemiology and impact of opioid use disorder as well as to highlight strategies to address stigma and promote patient-centered care.

Description

The opioid crisis was declared a Public Health Emergency in October of 2017. By June 2021, synthetic opioids were implicated in 87% of opioid deaths and 65% of all overdose deaths, and in April of 2022, the CDC estimated that over 108,000 drug overdose deaths occurred in the year prior. Even with the clearly imminent need to address Opioid Use Disorder (OUD), effective treatments, including medications for opioid use disorder (MOUD), are available but underutilized, with only 25% of those affected receiving specialty treatment. To address this disparity, this course will: - Review the epidemiology and impact of opioid use disorder; - Review treatment options, including the “gold standard” treatment of MOUD as well as complementary counseling and behavioral therapies, harm reduction, prevention, and non-opioid treatments; - Highlight strategies to address stigma and promote patient-centered care.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Nurse Practitioner
  • Physician
  • Psychologist
  • Social Worker

Presenters

Angelo Asheh, DO, MPH
Dr. Asheh is a double-board certified physician with a focus on mental health, addictions, and pain. Dr. Asheh currently serves as the Chief Medical Officer at the Hanley Foundation in West Palm Beach, FL. As an addiction medicine specialist, he completed his training at top institutions: Yale University, University of California San Diego, Loma Linda University, UConn, and Lenox Hill Hospital in NYC. He is a medical faculty member at UCSD and is a REACH scholar through SAMHSA, Yale University & AAAP. He has expertise in Addictions, Depression/Anxiety, ADHD, Psychopharmacology, Prevention, and Pain, Ketamine. He has additional training and expertise in TMS and Ketamine treatment. His particular interest is in childhood trauma.

Financially Sponsored By

  • Hanley Center